Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

NCT04205240 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Recurrent Plasma Cell Myeloma

Interventions

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
BIOLOGICAL: Daratumumab
DRUG: Fludarabine
DRUG: Melphalan
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus

Sponsor

Srinivas Devarakonda